Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Journal of Clinical Pharmacology
|
December 11, 2014
Effect of uptake transporters OAT3 and OATP1B1 and efflux transporter MRP2 on the pharmacokinetics of eluxadoline
J Michael Davenport, Paul Covington, Laura Bonifacio, et al.
Plos One
|
July 26, 2012
TH17, TH22 and Treg cells are enriched in the healthy human cecum
Martin J Wolff, Jacqueline M Leung, Michael Davenport, et al.
Antimicrobial Agents and Chemotherapy
|
September 28, 2011
Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection
Paul Covington, J Michael Davenport, David Andrae, et al.
Journal of Neurotrauma
|
January 25, 2006
Combined treatment with neurotrophin-3 and LSD facilitates behavioral recovery from double-hemisection spinal injury in neonatal rats
Victor L Arvanian, Honeyleen Manuzon, Michael Davenport, et al.
Optics Express
|
February 9, 2019
Heterogeneous silicon photonics sensing for autonomous cars
Weiqiang Xie, Tin Komljenovic, Jinxi Huang, et al.
Clinical Therapeutics
|
April 15, 2008
Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects
Ronald Christopher, Paul Covington, Michael Davenport, et al.
Clinical Therapeutics
|
April 15, 2008
Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes
Paul Covington, Ronald Christopher, Michael Davenport, et al.
Nature Reviews. Urology
|
March 2, 2017
New and developing diagnostic technologies for urinary tract infections
Michael Davenport, Kathleen E Mach, Linda M Dairiki Shortliffe, et al.
Clinical Pharmacology in Drug Development
|
April 29, 2016
Summary of Pharmacokinetics and Tissue Distribution of a Broad-Spectrum Fluoroquinolone, JNJ-Q2
J Michael Davenport, Paul Covington, Mark Gotfried, et al.
Aesthetic Surgery Journal
|
September 4, 2012
Aesthetic and functional satisfaction after monsplasty in the massive weight loss population
Jacob M P Bloom, Emily Van Kouwenberg, Michael Davenport, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Journal of Clinical Pharmacology
|
December 11, 2014
Effect of uptake transporters OAT3 and OATP1B1 and efflux transporter MRP2 on the pharmacokinetics of eluxadoline
J Michael Davenport, Paul Covington, Laura Bonifacio, et al.
Plos One
|
July 26, 2012
TH17, TH22 and Treg cells are enriched in the healthy human cecum
Martin J Wolff, Jacqueline M Leung, Michael Davenport, et al.
Antimicrobial Agents and Chemotherapy
|
September 28, 2011
Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection
Paul Covington, J Michael Davenport, David Andrae, et al.
Journal of Neurotrauma
|
January 25, 2006
Combined treatment with neurotrophin-3 and LSD facilitates behavioral recovery from double-hemisection spinal injury in neonatal rats
Victor L Arvanian, Honeyleen Manuzon, Michael Davenport, et al.
Optics Express
|
February 9, 2019
Heterogeneous silicon photonics sensing for autonomous cars
Weiqiang Xie, Tin Komljenovic, Jinxi Huang, et al.
Clinical Therapeutics
|
April 15, 2008
Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects
Ronald Christopher, Paul Covington, Michael Davenport, et al.
Clinical Therapeutics
|
April 15, 2008
Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes
Paul Covington, Ronald Christopher, Michael Davenport, et al.
Nature Reviews. Urology
|
March 2, 2017
New and developing diagnostic technologies for urinary tract infections
Michael Davenport, Kathleen E Mach, Linda M Dairiki Shortliffe, et al.
Clinical Pharmacology in Drug Development
|
April 29, 2016
Summary of Pharmacokinetics and Tissue Distribution of a Broad-Spectrum Fluoroquinolone, JNJ-Q2
J Michael Davenport, Paul Covington, Mark Gotfried, et al.
Aesthetic Surgery Journal
|
September 4, 2012
Aesthetic and functional satisfaction after monsplasty in the massive weight loss population
Jacob M P Bloom, Emily Van Kouwenberg, Michael Davenport, et al.
Page
of 3